https://orcid.org/0000-0002-6496-6504
References
- Norde W. My voyage of discovery to proteins in flatland …and beyond. Colloids Surf B Biointerfaces. 2008;61:1–9.
- Ke PC, Lin S, Parak WJ, et al.A decade of the protein corona. ACS Nano 2017;11:11773–11776.
- Docter D, Westmeier D, Markiewicz M, et al.The nanoparticle biomolecule corona: lessons learned–challenge accepted? Chem. Soc Rev 2015;44:6094–6121.
- Cai R, Chen C. The crown and the scepter: roles of the protein corona in nanomedicine. Adv Mater. 2018; 1805740.
- Malhaire H, Gimel J-C, Roger E, et al. How to design the surface of peptide-loaded nanoparticles for efficient oral bioavailability? . Adv. Drug Deliv Rev. 2016;106:320–336.
- McConnell EL, Fadda HM, Basit AW. Gut instincts: explorations in intestinal physiology and drug delivery. Int J Pharm [Internet]. 2008;364:213–226. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18602774
- Koziolek M, Grimm M, Schneider F, et al. Navigating the human gastrointestinal tract for oral drug delivery: uncharted waters and new frontiers. Adv Drug Deliv Rev. 2016;101:75–88.
- McClements DJ, Xiao H Is nano safe in foods? Establishing the factors impacting the gastrointestinal fate and toxicity of organic and inorganic food-grade nanoparticles. Npj Sci Food 2017;1:6.
- Ault AP, Stark DI, Axson JL, et al.Protein corona-induced modification of silver nanoparticle aggregation in simulated gastric fluid. Environ Sci Nano 2016;3:1510–1520.
- Pinďáková L, Kašpárková V, Kejlová K, et al. Behaviour of silver nanoparticles in simulated saliva and gastrointestinal fluids. Int J Pharm. 2017;527:12–20.
- Wang Y, Li M, Xu X, et al. Formation of protein corona on nanoparticles with digestive enzymes in simulated gastrointestinal fluids. J Agric Food Chem. 2019;67:2296–2306.
- Cao X, Han Y, Li F, et al. Impact of protein-nanoparticle interactions on gastrointestinal fate of ingested nanoparticles: not just simple protein corona effects. NanoImpact. 2019;13:37–43.
- Lichtenstein D, Ebmeyer J, Knappe P, et al.Impact of food components during in vitro digestion of silver nanoparticles on cellular uptake and cytotoxicity in intestinal cells. Biol Chem 2015;396:1255–1264.
- Siemer S, Hahlbrock A, Vallet C, et al.Nanosized food additives impact beneficial and pathogenic bacteria in the human gut: a simulated gastrointestinal study. Npj Sci Food 2018;2:22.
- Ball RL, Bajaj P, Whitehead KA Oral delivery of siRNA lipid nanoparticles: fate in the GI tract. Sci Rep 2018;8:2178.
- Di Silvio D, Rigby N, Bajka B, et al. Effect of protein corona magnetite nanoparticles derived from bread in vitro digestion on Caco-2 cells morphology and uptake. Int J Biochem Cell Biol. 2016;75:212–222.
- Berardi A, Baldelli Bombelli F, Thuenemann E, et al. Viral nanoparticles can elude protein barriers: exploiting rather than imitating nature. Nanoscale. 2019; 11:2306–2316.
- Berardi A, Evans DJ, Baldelli Bombelli F, et al.Stability of plant virus-based nanocarriers in gastrointestinal fluids. Nanoscale. 2018;10:1667–1679.
- Behzadi S, Serpooshan V, Sakhtianchi R, et al. Protein corona change the drug release profile of nanocarriers: the “overlooked” factor at the nanobio interface. Colloids Surf B Biointerfaces. 2014;123:143–149.
- Chakraborty D, Mohan L, Alex SA, et al.Bimetallic gold nanorods with enhanced biocorona formation for doxorubicin loading and sustained release. Biomater Sci 2019;7:63–75.
- Peng Q, Wei X-Q, Yang Q, et al.Enhanced biostability of nanoparticle-based drug delivery systems by albumin corona. Nanomedicine. 2015;10:205–214.
- Al-Ahmady ZS, Hadjidemetriou M, Gubbins J, et al. Formation of protein corona in vivo affects drug release from temperature-sensitive liposomes. J Control Release. 2018;276:157–167.
- Mahmoudi M, Sheibani S, Milani AS, et al.Crucial role of the protein corona for the specific targeting of nanoparticles. Nanomedicine. 2015;10:215–226.
- Wang A, Yang T, Fan W, et al. Protein corona liposomes achieve efficient oral insulin delivery by overcoming mucus and epithelial barriers. Adv Healthc Mater. 2018;1801123.